Lilly Endowment reports 9.6% stake in Eli Lilly in updated 13G

Lilly Endowment, Inc. owned 90,066,978 shares of Eli Lilly and Company as of Sept. 30, according to an amended Schedule 13G filed Oct. 19.

The stake equals 9.6% of Lilly's common stock, based on 941,357,065 shares outstanding as of Aug. 3, 2026, as reported in Lilly's most recent quarterly report.

The endowment reported sole voting power and sole dispositive power over all of the shares, with no shared power. None of the shares are counted because of a right to acquire stock, the filing says.

About the holder

Lilly Endowment is an Indiana nonprofit corporation and a private foundation under Section 509(a) of the Internal Revenue Code, according to the filing. It is based in Indianapolis.

The filing is Amendment No. 47 to the endowment's Schedule 13G on Lilly stock.

Sources

1. Lilly Endowment, Inc. Schedule 13G/A for Eli Lilly and Company, filed Oct. 19, 2026, accession 0000316011-26-000036

This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.

Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.